It is a known fact that diabetes is one of the most prevalent lifestyle disorder in the world. But, due to advances in research, we have witnessed a shift in paradigm in recent times. Many molecules have been discovered in the last four decades. The discovery is now heading towards patient-centric problems focusing on quality of life.
Only criteria which hinder the situation is the cost of molecules and explaining the cost-benefit ratio. This exclusive commentary focuses on case series for explaining a paradigm shift in Type 2 diabetes.
